BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Merus N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:35 am Sale | 2023-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,420 4.800% | -226,000 (-7.59%) | Filing |
| 2023-02-14 12:03 pm Sale | 2022-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,978,420 6.400% | -1,156,651 (-27.97%) | Filing |
| 2022-02-11 7:22 pm Sale | 2021-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.600% | -925,000 (-18.28%) | Filing |
| 2021-07-07 4:35 pm Sale | 2021-07-02 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.200% | -745,500 (-12.84%) | Filing |
| 2021-02-12 4:16 pm Purchase | 2020-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,805,571 19.960% | 815,000 (+16.33%) | Filing |